Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Chemical modification or the reaction product thereof – e.g.,...
Reexamination Certificate
2003-06-04
2009-06-16
Ewoldt, G. R (Department: 1644)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Chemical modification or the reaction product thereof, e.g.,...
C530S350000
Reexamination Certificate
active
07547769
ABSTRACT:
The invention relates to immunomodulators. In particular the invention relates to specific immunomodulators based on the superantigen SMEZ-2 and more particularly based on mutants of the superantigen SMEZ-2, which are adapted to target antigen-presenting-cells for the purpose of enhancing or suppressing a host immune response.
REFERENCES:
patent: 5116964 (1992-05-01), Capon et al.
patent: 5545716 (1996-08-01), Johnson et al.
patent: 5698679 (1997-12-01), Nemazee
patent: 5728388 (1998-03-01), Terman
patent: 5858363 (1999-01-01), Dohlsten et al.
patent: 5859207 (1999-01-01), Johnson et al.
patent: 5968514 (1999-10-01), Johnson et al.
patent: 6042837 (2000-03-01), Kalland et al.
patent: 6095315 (2000-08-01), Andersch et al.
patent: 6126945 (2000-10-01), Terman et al.
patent: 6180097 (2001-01-01), Terman
patent: 6197299 (2001-03-01), Dohlsten et al.
patent: 6221351 (2001-04-01), Terman
patent: 6251385 (2001-06-01), Terman
patent: 6338845 (2002-01-01), Terman
patent: 6340461 (2002-01-01), Terman
patent: 6514498 (2003-02-01), Antonsson et al.
patent: 6692746 (2004-02-01), Terman et al.
patent: 2003/0092894 (2003-05-01), Antonsson et al.
patent: 0 766 566 (2001-04-01), None
patent: WO 93/14634 (1993-08-01), None
patent: WO 00/39159 (2000-07-01), None
patent: WO 02/11619 (2002-02-01), None
patent: 02/45739 (2002-06-01), None
Parks et al., May 2002, J. General Virol. vol. 83: 1167-1172.
Yan et al., “Characterization of Monoclonal Antibodies to the 26-kDa Glutathione S-transferase of Schistosoma japonicum”, 1996, Hybridoma, vol. 15:429-33.
Hong-Gellar et al., “Therapeutic approaches to superantigen-based disease: a review”, 2003, J. Mol. Rec. , vol. 16:91-101.
Arcus et al. “Conservation and variation in superantigen structure and activity highlighted by the three-dimensional structures of two new superantigens fromstreptococcus pyogenes”. Biology 299:157-168, 2000.
Proft et al. “The streptococcal superantigen SMEZ exhibits wide allelic variation, mosaic structure, and significant antigenic variation”. J. Exp. Med. 191(10):1765-1776, May 2000.
Unnikrishnan et al. “The bacterial superantigen streptococcal mitogenic exotoxin Z is the major immunoactive agent ofstreptococcus pyogenes”. The Journal of Immunology 169:2561-2569, 2002.
Li et al. “Three-dimensional structure of the complex between a T cell receptor β chain and the superantigen staphylococcal enterotoxin B”. Immunity 9:807-816, Dec. 1998.
Fraser et al. “Superantigens—powerful modifiers of the immune system”. Molecular Medicine 6:125-132, Mar. 2000.
Leder et al. “A Mutational analysis of the binding of staphylococcal enterotoxins B and C3 to the T cell receptor β chain and major histocompatibility complex class II”. J. Exp. Med. 187(6):823-833, Mar. 1998.
Lukas Leder et al. “A mutational analysis of the binding of staphylococcal enterotoxins B and C3 to the T cell receptor beta chain and major histocompatibility complex class II”. Journal of Experimental Medicine 187(6):823-833, Mar. 16, 1998.
Hongmin Li et al. “Three-dimensional structure of the complex between a T cell receptor beta chain and the superantigen staphylococcal exterotoxin B”. Immunity 9(6):807-816, Dec. 1998.
John Fraser et al. “Superantigens: Powerful modifiers of the immune system”. Molecular Medicine Today 6(3):125-132, Mar. 2000.
McCormick, John K. et al. “Development of Streptococcal Pyrogenic Exotoxin C Vaccine Toxoids that are Protective in the Rabbit Model of Toxic Shock Syndrome.”The Journal of Immunology(2000), pp. 2306-2312.
Nestle et al., “Human Dermal Dendritic Cells Process and Present Soluble Protein Antigens”, The Journal of Investigative Dermatology, vol. 110, No. 5, May 1998, pp. 762-766.
Auckland Uniservices Limited
Ewoldt G. R
Juedes Amy E
Occhiuti Rohlicek & Tsao LLP
LandOfFree
Immunomodulatory constructs and their uses does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunomodulatory constructs and their uses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunomodulatory constructs and their uses will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4113177